Clinical Trial Update: A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Avenciguat in patients with liver cirrhosis and portal hypertension who had esophageal bleeding or ascites was terminated, and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Avenciguat

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Portal, Liver Cirrhosis | Phase 2 | Status: TERMINATED | Results posted: 2025-06-12